| APO-CEPHALEX (500 MG)Apotex Inc. · Status since Dec 1988 | 00768715 | Marketed | Apotex Inc. | Dec 1988 |
| APO-CEPHALEX (250 MG)Apotex Inc. · Status since Dec 1988 | 00768723 | Marketed | Apotex Inc. | Dec 1988 |
| AURO-CEPHALEXIN (250 MG)Auro Pharma Inc. · Status since Jul 2018 | 02470578 | Marketed | Auro Pharma Inc. | Jul 2018 |
| AURO-CEPHALEXIN (500 MG)Auro Pharma Inc. · Status since Jul 2018 | 02470586 | Marketed | Auro Pharma Inc. | Jul 2018 |
| AURO-CEPHALEXIN (125 MG)Auro Pharma Inc. · Status since Jul 2020 | 02497743 | Marketed | Auro Pharma Inc. | Jul 2020 |
| AURO-CEPHALEXIN (250 MG)Auro Pharma Inc. · Status since Jul 2020 | 02497751 | Marketed | Auro Pharma Inc. | Jul 2020 |
| CEFASEPTIN 300 MG (300 MG)Vetoquinol N A Inc · Status since Aug 2017 | 02463369 | Marketed | Vetoquinol N A Inc | Aug 2017 |
| CEFASEPTIN 750 MG (750 MG)Vetoquinol N A Inc · Status since Aug 2017 | 02463385 | Marketed | Vetoquinol N A Inc | Aug 2017 |
| CEPHALEXIN (500 MG)Sivem Pharmaceuticals Ulc · Status since Oct 2020 | 02495651 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2020 |
| CEPHALEXIN (250 MG)Sanis Health Inc. · Status since May 2022 | 02521253 | Marketed | Sanis Health Inc. | May 2022 |
| CEPHALEXIN (500 MG)Sanis Health Inc. · Status since May 2022 | 02521261 | Marketed | Sanis Health Inc. | May 2022 |
| JAMP CEPHALEXIN (250 MG)JAMP Pharma Corporation · Status since Jan 2023 | 02494698 | Marketed | JAMP Pharma Corporation | Jan 2023 |
| JAMP CEPHALEXIN (500 MG)JAMP Pharma Corporation · Status since Jan 2023 | 02494701 | Marketed | JAMP Pharma Corporation | Jan 2023 |
| JAMP CEPHALEXIN SUSPENSION (125 MG)JAMP Pharma Corporation · Status since Feb 2023 | 02528436 | Marketed | JAMP Pharma Corporation | Feb 2023 |
| JAMP CEPHALEXIN SUSPENSION (250 MG)JAMP Pharma Corporation · Status since Feb 2023 | 02528444 | Marketed | JAMP Pharma Corporation | Feb 2023 |
| LUPIN-CEPHALEXIN (125 MG)Lupin Pharma Canada Limited · Status since Dec 2018 | 02469170 | Marketed | Lupin Pharma Canada Limited | Dec 2018 |
| LUPIN-CEPHALEXIN (250 MG)Lupin Pharma Canada Limited · Status since Dec 2018 | 02469189 | Marketed | Lupin Pharma Canada Limited | Dec 2018 |
| LUPIN-CEPHALEXIN (250 MG)Lupin Pharma Canada Limited · Status since Sep 2025 | 02471140 | Marketed | Lupin Pharma Canada Limited | Sep 2025 |
| LUPIN-CEPHALEXIN (500 MG)Lupin Pharma Canada Limited · Status since Sep 2025 | 02471159 | Marketed | Lupin Pharma Canada Limited | Sep 2025 |
| PRO-CEPHALEXIN (250 MG)Pro Doc Limitee · Status since Feb 2026 | 02562596 | Marketed | Pro Doc Limitee | Feb 2026 |
| RILEXINE CHEWABLE TABLETS (300 MG)Virbac Ah, Inc. · Status since Feb 2022 | 02442701 | Marketed | Virbac Ah, Inc. | Feb 2022 |
| RILEXINE CHEWABLE TABLETS (600 MG)Virbac Ah, Inc. · Status since Feb 2022 | 02442728 | Marketed | Virbac Ah, Inc. | Feb 2022 |
| TEVA-CEPHALEXIN (250 MG)Teva Canada Limited · Status since Jul 2014 | 00342084 | Marketed | Teva Canada Limited | Jul 2014 |
| TEVA-CEPHALEXIN (500 MG)Teva Canada Limited · Status since Jul 2014 | 00342114 | Marketed | Teva Canada Limited | Jul 2014 |
| TEVA-CEPHALEXIN (250 MG)Teva Canada Limited · Status since Jul 2014 | 00583413 | Marketed | Teva Canada Limited | Jul 2014 |
| TEVA-CEPHALEXIN (500 MG)Teva Canada Limited · Status since Jul 2014 | 00583421 | Marketed | Teva Canada Limited | Jul 2014 |
| TEVA-CEPHALEXIN 125 (125 MG)Teva Canada Limited · Status since Jul 2014 | 00342106 | Marketed | Teva Canada Limited | Jul 2014 |
| TEVA-CEPHALEXIN 250 (250 MG)Teva Canada Limited · Status since Jul 2014 | 00342092 | Marketed | Teva Canada Limited | Jul 2014 |
| ASN-CEPHALEXIN (125 MG)Ascend Laboratories Ltd · Status since Feb 2020 | 02496445 | Approved | Ascend Laboratories Ltd | Feb 2020 |
| ASN-CEPHALEXIN (250 MG)Ascend Laboratories Ltd · Status since Feb 2020 | 02496453 | Approved | Ascend Laboratories Ltd | Feb 2020 |
| CEFASEPTIN 75 MG (75 MG)Vetoquinol N A Inc · Status since May 2017 | 02463350 | Approved | Vetoquinol N A Inc | May 2017 |
| KEFLEX (125 MG)Pendopharm Division Of Pharmascience Inc · Status since Aug 2017 | 00015547 | Dormant | Pendopharm Division Of Pharmascience Inc | Aug 2017 |
| KEFLEX (250 MG)Pendopharm Division Of Pharmascience Inc · Status since Aug 2018 | 00035645 | Dormant | Pendopharm Division Of Pharmascience Inc | Aug 2018 |
| KEFLEX (500 MG)Pendopharm Division Of Pharmascience Inc · Status since Aug 2017 | 00244392 | Dormant | Pendopharm Division Of Pharmascience Inc | Aug 2017 |
| KEFLEX (250 MG)Pendopharm Division Of Pharmascience Inc · Status since Aug 2017 | 00403628 | Dormant | Pendopharm Division Of Pharmascience Inc | Aug 2017 |
| PRO-CEPHALEXIN (125 MG)Pro Doc Limitee · Status since Oct 2025 | 02562588 | Approved | Pro Doc Limitee | Oct 2025 |
| RILEXINE CHEWABLE TABLETS (150 MG)Virbac Ah, Inc. · Status since Jun 2015 | 02442698 | Approved | Virbac Ah, Inc. | Jun 2015 |
| CEPHALEXIN TAB 250MG (250 MG)Pro Doc Limitee · Status since Jul 2012 | 00828858 | Cancelled Post Market | Pro Doc Limitee | Jul 2012 |
| CEPHALEXIN-500 (500 MG)Pro Doc Limitee · Status since Jul 2022 | 00828866 | Cancelled Post Market | Pro Doc Limitee | Jul 2022 |
| DOM-CEPHALEXIN - TAB 250MG (250 MG)Dominion Pharmacal · Status since Oct 2019 | 02177846 | Cancelled Post Market | Dominion Pharmacal | Oct 2019 |
| DOM-CEPHALEXIN - TAB 500MG (500 MG)Dominion Pharmacal · Status since Oct 2019 | 02177854 | Cancelled Post Market | Dominion Pharmacal | Oct 2019 |
| DOM-CEPHALEXIN 125 - SUS 125MG/5ML (125 MG)Dominion Pharmacal · Status since Oct 2019 | 02177862 | Cancelled Post Market | Dominion Pharmacal | Oct 2019 |
| DOM-CEPHALEXIN 250 - SUS 250MG/5ML (250 MG)Dominion Pharmacal · Status since Oct 2019 | 02177870 | Cancelled Post Market | Dominion Pharmacal | Oct 2019 |
| NU-CEPHALEX TAB 250MG (250 MG)Nu-Pharm Inc · Status since Sep 2012 | 00865877 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| NU-CEPHALEX TAB 500MG (500 MG)Nu-Pharm Inc · Status since Sep 2012 | 00865885 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| PENTA-CEPHALEXIN - 250MG (250 MG)Pentapharm Ltd. · Status since Jul 2004 | 02229587 | Cancelled Post Market | Pentapharm Ltd. | Jul 2004 |
| PENTA-CEPHALEXIN - 500MG (500 MG)Pentapharm Ltd. · Status since Jul 2004 | 02229588 | Cancelled Post Market | Pentapharm Ltd. | Jul 2004 |
| PMS-CEPHALEXIN - TAB 250MG (250 MG)Pharmascience Inc. · Status since Jul 2025 | 02177781 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| PMS-CEPHALEXIN - TAB 500MG (500 MG)Pharmascience Inc. · Status since Jul 2025 | 02177803 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| PMS-CEPHALEXIN 125 - SUS 125MG/5ML (125 MG)Pharmascience Inc. · Status since Jul 2025 | 02177811 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| PMS-CEPHALEXIN 250 - SUS 250MG/5ML (250 MG)Pharmascience Inc. · Status since Jul 2025 | 02177838 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| STCC-CEPHALEXIN -TAB 250MG (250 MG)Stcc Inc. · Status since Jul 2002 | 02180758 | Cancelled Post Market | Stcc Inc. | Jul 2002 |
| STCC-CEPHALEXIN -TAB 500MG (500 MG)Stcc Inc. · Status since Jul 2002 | 02180766 | Cancelled Post Market | Stcc Inc. | Jul 2002 |
| STCC-CEPHALEXIN 125 - ORL SUS 125MG/5ML (125 MG)Stcc Inc. · Status since Jul 2002 | 02180774 | Cancelled Post Market | Stcc Inc. | Jul 2002 |
| STCC-CEPHALEXIN 250 - SUS ORL 250MG/5ML (250 MG)Stcc Inc. · Status since Jul 2002 | 02180782 | Cancelled Post Market | Stcc Inc. | Jul 2002 |
| VETOLEXIN 100 (100 MG)Vetoquinol N A Inc · Status since Feb 2019 | 02353911 | Cancelled Post Market | Vetoquinol N A Inc | Feb 2019 |
| VETOLEXIN 250 (250 MG)Vetoquinol N A Inc · Status since Feb 2018 | 02353938 | Cancelled Post Market | Vetoquinol N A Inc | Feb 2018 |